Igc Pharma Inc (IGC) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Igc Pharma Inc   (NYSEAMER: IGC)


Igc Pharma Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



IGC Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Sep 30 2025)
Q2
(Jun 30 2025)
Q1
Y / Y Revenue Change 0 %
Seq. Revenue Change 23.77 %
Revenue In Millions $0.33
Gross Profit Margin 18.6 %
Gross Profit Margin Total Ranking # 3021
Gross Profit In Millions $0.06
Y / Y Gross Profit Change -60.39 %
Seq. Gross Profit Change 27.08 %


Commenting Third Quarter 2026 Gross Profit Margin
Igc Pharma Inc Gross Profit grew by 27.08 % in Q3 sequentially to 0 millions, while Revenue increased by 23.77 %, this led to improvement in the company's Gross Profit Margin to 18.6 %, Gross Profit Margin remained below Igc Pharma Inc average.


Observing third quarter 2026 results within Major Pharmaceutical Preparations industry 136 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3021.
Learn about Gross Margin
IGC's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 137
Healthcare Sector # 421
Overall # 2996

Gross Profit Margin Statistics
High Average Low
87 % 30.27 % 1.54 %
(Jun 30 2017)   (Sep 30 2019)




Other Gross Profit Margin Profitability Ratios
IGC's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
IGC's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for IGC's Competitors
Gross Profit Margin Profit Margin for Igc Pharma Inc 's Suppliers
Gross Profit Margin Profit Margin for IGC's Customers

You may also want to know
IGC's Annual Growth Rates IGC's Profitability Ratios IGC's Asset Turnover Ratio IGC's Dividend Growth
IGC's Roe IGC's Valuation Ratios IGC's Financial Strength Ratios IGC's Gross Profit Growth
IGC's Roa IGC's Inventory Turnover Ratio IGC's Growth Rates IGC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Bausch Health Companies Inc   50.02 %$ 1,471.000  Millions$ 2,941.000  Millions
Amphastar Pharmaceuticals Inc   47.99 %$ 99.629  Millions$ 207.608  Millions
Cryoport inc   47.46 %$ 23.834  Millions$ 50.220  Millions
Collegium Pharmaceutical Inc   41.53 %$ 89.843  Millions$ 216.339  Millions
Amarin Corp Plcuk  40.66 %$ 16.181  Millions$ 39.799  Millions
Elite Pharmaceuticals Inc   39.89 %$ 15.987  Millions$ 40.082  Millions
Amneal Pharmaceuticals Inc   38.73 %$ 334.118  Millions$ 862.684  Millions
Viatris Inc   38.35 %$ 1,438.000  Millions$ 3,749.500  Millions
Maravai Lifesciences Holdings Inc   35.31 %$ 16.192  Millions$ 45.851  Millions
Phibro Animal Health Corporation  33.23 %$ 128.537  Millions$ 386.774  Millions
Sunshine Biopharma Inc   32.85 %$ 3.102  Millions$ 9.442  Millions
Perrigo Company Plc  32.45 %$ 320.800  Millions$ 988.600  Millions
Emergent Biosolutions Inc   26.55 %$ 29.200  Millions$ 110.000  Millions
Igc Pharma Inc   18.60 %$ 0.061  Millions$ 0.328  Millions
Rockwell Medical inc   16.27 %$ 3.111  Millions$ 19.122  Millions
Dogwood Therapeutics inc   11.90 %$ 0.012  Millions$ 0.100  Millions
Quantum Cyber N v   9.68 %$ 0.094  Millions$ 0.967  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.